Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,548.17
-13.1079-0.84%
Number of Gainers:1
Number of Losers:6
Number of Flat:- -
PE:- -
High:1,569.66
Open:1,563.81
Low:1,545.55
Close:1,561.28
Volume:46.03M
Turnover:4.18B
Market Cap:1.61T
Float Cap:1.55T

Loading ...

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS
·
Aug 31

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Aug 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Aug 31

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Aug 31

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Aug 31

Pfizer Pivots: New Trials Target Obesity, Cancer, Autoimmune

TIPRANKS
·
Aug 29

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.
·
Aug 29

Pfizer EVP Cecile Guegan Files Initial Beneficial Ownership Statement

Reuters
·
Aug 29

Pfizer Extends Tucatinib Access With New Continuation Study: What Investors Should Know

TIPRANKS
·
Aug 29

Pfizer Expands Autoimmune Pipeline With New Early-Stage Trial of PF-08154225

TIPRANKS
·
Aug 29

Pfizer Targets China’s Obesity Market With New Phase 3 Berobenatide Trial

TIPRANKS
·
Aug 29

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

TIPRANKS
·
Aug 29

Novo Nordisk A/S Series B Stock Rises Friday

Dow Jones
·
Aug 29

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

Political and General News Events from August 28

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Novo Nordisk Share Price Already Reflects Plenty of Pessimism

Dow Jones
·
Aug 28